Owner foundation to sell Leo Pharma stake
The foundation behind Leo Pharma plans to divest parts of the Danish pharmaceutical company, in part to secure Leo Pharma’s options in realizing a new 2030 strategy. The foundation’s CEO keeps options open – even going on the stock exchange.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Denmark’s third-largest pharmaceutical company, Leo Pharma, might have some new owners to get used to.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
